🕵️ Transcode Therapeutics, Inc. ($RNAZ)
SEC insider & ownership activity, last 12 months · CIK 1829635 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. 2 red-flag 8-Ks in the window, most recently Delisting notice (3.01), May 19, 2026.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| DEFJ, LLC | 83.9% | 13D | Aug 3, 2026 | filing ↗ | |
| CK Life Sciences Int'l., (HOLDINGS) Inc. | 83.9% | 13D | Aug 3, 2026 | filing ↗ | |
| Unleash Immuno Oncolytics, Inc. | 9.9% | 13G | Jul 28, 2026 | filing ↗ | |
| YA II PN, Ltd. | 9.9% | 13G | Apr 20, 2026 | filing ↗ | |
| YA Global Investments II (U.S.), LP | 9.9% | 13G | Apr 20, 2026 | filing ↗ | |
| Yorkville Advisors Global, LP | 9.9% | 13G | Apr 20, 2026 | filing ↗ | |
| Yorkville Advisors Global II, LLC | 9.9% | 13G | Apr 20, 2026 | filing ↗ | |
| YAII GP, LP | 9.9% | 13G | Apr 20, 2026 | filing ↗ | |
| YAII GP II, LLC | 9.9% | 13G | Apr 20, 2026 | filing ↗ | |
| Mark Angelo | 9.9% | 13G | Apr 20, 2026 | filing ↗ | |
| SC-Sigma Global Partners, LP | 9.9% | 13G | Apr 20, 2026 | filing ↗ | |
| Elena Rosa Braci | 6.2% | 13G | Jul 28, 2026 | filing ↗ | |
| Daniel Eduardo Katzman | 5.2% | 13G | Jul 28, 2026 | filing ↗ | |
| Thomas Joseph Tracy | 5.0% | 13D | Mar 7, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Sep 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 9, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Aug 3, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Aug 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 3, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jul 20, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Jul 16, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jul 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 16, 2026 | filing ↗ |
| Other events (8.01) | Jul 2, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 18, 2026 | filing ↗ |
| Other events (8.01) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 (5.08) | May 29, 2026 | filing ↗ |
| Delisting notice (3.01) | May 19, 2026 | filing ↗ |
| Delisting notice (3.01) | May 19, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 6, 2026 | filing ↗ |
| New financial obligation (2.03) | Apr 6, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 6, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 2, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Mar 2, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Mar 2, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 2, 2026 | filing ↗ |
| Other events (8.01) | Mar 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 2, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 23, 2026 | filing ↗ |